Drupal.behaviors.print = function(context) {window.print();window.close();}>
Agilent Q3 Revenues up 2 Percent; Lowers FY 2012 Estimates
August 16, 2012
Agilent Q3 Revenues up 2 Percent; Lowers FY 2012 Estimates
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
FDA Approves Dako Assays as CDx for Genentech Breast Cancer Drug
March 5, 2013 / GenomeWeb Daily News
FDA Approves Dako's HER2 IQFISH Assay
February 15, 2013 / GenomeWeb Daily News
Dako, Pfizer Reach Companion Dx Deal
February 12, 2013 / GenomeWeb Daily News
Dako Acquires IP from System Dynamics
December 26, 2012 / GenomeWeb Daily News
Agilent Offering Senior Notes, Restates Earnings to Reflect Dako Purchase
September 10, 2012 / GenomeWeb Daily News